Allergy, Asthma & Clinical Immunology (May 2010)

A systematic review of the efficacy and safety of a purified, pasteurized C1 inhibitor concentrate for the treatment of patients with type I or II hereditary angioedema

  • Bork K,
  • Steffense I,
  • Neme A,
  • Morrison A,
  • van den Hoef G,
  • Barnes D

DOI
https://doi.org/10.1186/1710-1492-6-S1-P32
Journal volume & issue
Vol. 6, no. Suppl 1
p. P32

Abstract

Read online

No abstracts available.